Efficacy of Gemtuzumab Ozogamicin (GO) Monotherapy on Relapsed/Refractory Acute Promyelocytic Leukemia (APL)

被引：0

作者：

Takeshita, Akihiro ^{[1
]}

Ono, Takaaki ^{[1
]}

Kojima, Yumi ^{[2
]}

Kyo, Taiichi ^{[3
]}

Asou, Norio ^{[4
]}

Suzushima, Hitoshi ^{[5
]}

Yagasaki, Fumiharu ^{[6
]}

Maeda, Tomoya ^{[7
]}

Okada, Masaya ^{[8
]}

Nakaseko, Chiaki ^{[9
]}

Kanbayashi, Hiroyuki ^{[10
]}

Yamaguchi, Masaki ^{[11
]}

Kurosawa, Mitsutoshi ^{[12
]}

Tsuboi, Kosuke ^{[13
]}

Yujiri, Toshiaki ^{[14
]}

Nannya, Yasuhito ^{[15
]}

Uike, Naokuni ^{[16
]}

Akiyama, Nobu ^{[17
]}

Fukuda, Tetsuya ^{[18
]}

Karimata, Kaori ^{[19
]}

Okumura, Hirokazu ^{[20
]}

Eto, Tetsuya ^{[21
]}

Izumiyama, Koh ^{[22
]}

Watanabe, Akihiro ^{[23
]}

Aotsuka, Nobuyuki ^{[24
]}

Ito, Katsuro ^{[25
]}

Ozaki, Keiji ^{[26
]}

Naoe, Tomoki ^{[27
]}

机构：

[1] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan

[2] Ekisaikai Hosp, Nagoya, Aichi, Japan

[3] Hiroshima Red Cross Hosp, Hiroshima, Japan

[4] Kumamoto Univ, Kumamoto, Japan

[5] NTT W Kyushu Hsp, Kumamoto, Japan

[6] Saitama Med Univ, Kawagoe, Saitama, Japan

[7] Saitama Med Univ, Int Med Ctr, Hidaka, Japan

[8] Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan

[9] Chiba Univ Hosp, Dept Hematol, Chiba, Japan

[10] Ohta Nishikouchi Hosp, Koriyama, Japan

[11] Ishikawa Prefectural Cent Hosp, Kanazawa, Ishikawa, Japan

[12] Hokkaido Cooperat Hematol Grp, Sapporo, Hokkaido, Japan

[13] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan

[14] Yamaguchi Univ, Sch Med, Dept Int Med 3, Ube, Yamaguchi 755, Japan

[15] Univ Tokyo, Tokyo, Japan

[16] Natl Hosp Org, Kyushu Canc Ctr, Fukuoka, Japan

[17] Teikyo Univ, Sch Med, Tokyo 173, Japan

[18] Tokyo Med & Dent Univ, Tokyo, Japan

[19] Heart Life Hosp, Nakagakigun, Japan

[20] Toyama Prefectural Cent Hosp, Toyama, Japan

[21] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan

[22] Hokkaido PWFAC Obihiro Kosei Gen Hosp, Obihiro, Hokkaido, Japan

[23] Niigata Canc Ctr Hosp, Niigata, Japan

[24] Narita Red Cross Hosp, Narita, Japan

[25] Ogawa Red Cross Hosp, Ogawa, Japan

[26] Tokushima Red Cross Hosp, Komatsushima, Japan

[27] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan

来源：

BLOOD | 2011年 / 118卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：665 / 666

页数：2

共 50 条

[1] Use of Gemtuzumab Ozogamicin for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML) or Acute Promyelocytic Leukemia (APL) in an Expanded Access Setting at Our Cancer Consortium
Gardner, Kelda M.
Dorcy, Kathleen Shannon
O'Leary, Rachele
Rizzuto, Donelle
Walter, Roland B.
Shaw, Carole
So, Sunny
Hendrie, Paul C.
Scott, Bart L.
Percival, Mary Beth M.
Halpern, Anna B.
Cassaday, Ryan D.
Abkowitz, Janis L.
Murphy, Bethany
Curley, Niall
Hammer, Cody
Smith, Heather
Zecha, Gabrielle A.
Appelbaum, Frederick R.
Meshinchi, Soheil
Delaney, Colleen
Cooper, Todd M.
Tarlock, Katherine
Estey, Elihu H.
Becker, Pamela S.
BLOOD, 2018, 132
[2] Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells
A Takeshita
K Shinjo
K Naito
H Matsui
N Sahara
K Shigeno
T Horii
N Shirai
M Maekawa
K Ohnishi
T Naoe
R Ohno
Leukemia, 2005, 19 : 1306 - 1311
[3] Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells
Takeshita, A
Shinjo, K
Naito, K
Matsui, H
Sahara, N
Shigeno, K
Horii, T
Shirai, N
Maekawa, M
Ohnishi, K
Naoe, T
Ohno, R
LEUKEMIA, 2005, 19 (08) : 1306 - 1311
[4] Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemia
Azuma, Yoshiko
Nakaya, Aya
Hotta, Masaaki
Fujita, Shinya
Tsubokura, Yukie
Yoshimura, Hideaki
Satake, Atsushi
Ishii, Kazuyoshi
Ito, Tomoki
Nomura, Shosaku
MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (01) : 31 - 34
[5] Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia
Lo-Coco, F
Cimino, G
Breccia, M
Noguera, NI
Diverio, D
Finolezzi, E
Pogliani, EM
Di Bona, E
Micalizzi, C
Kropp, M
Venditti, A
Tafuri, A
Mandelli, F
BLOOD, 2004, 104 (07) : 1995 - 1999
[6] Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas
Piccaluga, PP
Martinelli, G
Rondoni, M
Malagola, M
Gaitani, S
Isidori, A
Bonini, A
Gugliotta, L
Luppi, M
Morselli, M
Sparaventi, G
Visani, G
Baccarani, M
LEUKEMIA & LYMPHOMA, 2004, 45 (09) : 1791 - 1795
[7] Gemtuzumab ozogamicin (Mylotarg®) in children with refractory or relapsed acute myeloid leukemia
Reinhardt, D
Diekamp, S
Fleischhack, G
Corbacioglu, S
Jürgens, H
Dworzak, M
Kaspers, G
Creutzig, U
Zwaan, CM
ONKOLOGIE, 2004, 27 (03): : 269 - 272
[8] Azacitidine combined with gemtuzumab ozogamicin in patients with relapsed/refractory acute myeloid leukemia
Bayraktar, Ulas Darda
Domingo, Gelenis Calzadilla
Schmit, Jessica
Pereira, Denise
LEUKEMIA & LYMPHOMA, 2011, 52 (05) : 913 - 915
[9] Safety and efficacy of pracinostat in combination with gemtuzumab ozogamicin (PraGO) in patients with relapsed/refractory acute myeloid leukemia
Abedin, Sameem M.
Badar, Talha
Gauger, Katelyn
Michaelis, Laura C.
Runaas, Lyndsey
Carlson, Karen-Sue
Murthy, G. S. Guru
Atallah, Ehab
LEUKEMIA RESEARCH, 2022, 123
[10] Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemia
Chantepie, Sylvain P.
Reboursiere, Emilie
Mear, Jean-Baptiste
Gac, Anne-Claire
Salaun, Veronique
Benabed, Khaled
Cheze, Stephane
Johnsonansah, Hyacinthe
Macro, Margaret
Vilque, Jean-Pierre
Reman, Oumedaly
LEUKEMIA & LYMPHOMA, 2015, 56 (08) : 2326 - 2330

← 1 2 3 4 5 →